Nutley, NJ, United States of America

Charanjit R Behl


Average Co-Inventor Count = 1.8

ph-index = 3

Forward Citations = 80(Granted Patents)


Location History:

  • Bloomfield, NJ (US) (1985 - 1988)
  • Nutley, NJ (US) (1996)

Company Filing History:


Years Active: 1985-1996

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Charanjit R Behl: Innovator in Pharmaceutical Compositions

Introduction

Charanjit R Behl is a notable inventor based in Nutley, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of transdermal delivery systems. With a total of 4 patents to his name, Behl's work has the potential to impact the way medications are administered.

Latest Patents

Among his latest patents, Behl has developed a pharmaceutical composition for transdermal delivery that includes an effective amount of an active ingredient selected from a benzodiazepine and a benzodiazepine antagonist. This composition comprises isopropanol, propylene glycol, oleic acid, and water. Additionally, it may contain diacetin, Cetiol B.RTM., caprylic acid, silicon fluid, Miglyol.RTM. 840, or transcutol. Another significant patent focuses on a similar pharmaceutical composition for transdermal delivery, which includes ethanol, caprylic acid, and oleic acid, along with optional ingredients such as silicon fluid, benzyl alcohol, transcutol, or dimethyl sulfoxide.

Career Highlights

Charanjit R Behl is currently associated with Hoffmann-La Roche Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving drug delivery methods, which can enhance patient compliance and therapeutic outcomes.

Collaborations

Behl has collaborated with notable colleagues such as Joel Unowsky and George Beskid, contributing to a dynamic work environment that fosters innovation and creativity.

Conclusion

Charanjit R Behl's contributions to pharmaceutical compositions, particularly in transdermal delivery, highlight his role as an influential inventor in the industry. His ongoing work at Hoffmann-La Roche Inc. continues to pave the way for advancements in medication administration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…